Drug Topics
MAY 8, 2023
A new CDC report on data collected by the Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder During Pregnancy, indicates that medication for opioid use disorder is more often given to individuals who are White, older, and have private insurance.
PhRMA
MAY 8, 2023
Indiana just joined West Virginia and Arkansas in delivering an important win for Hoosiers who are struggling to afford their medicines. This week, Governor Holcomb signed into law Senate Bill 8 recently passed by the Indiana legislature. This new law will ensure that Indiana patients aren’t paying more for their medicines than their health insurance company or the middlemen known as pharmacy benefit managers (PBMs).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 8, 2023
Patients with advanced or recurrent endometrial cancer treated with Keytruda plus chemotherapy had improved progression-free survival compared with chemotherapy alone.
PhRMA
MAY 8, 2023
Researching and developing new medicines for children is a priority for the biopharmaceutical industry. Despite the scientific complexity and challenges inherent to developing treatments for our youngest patients, there has never been more progress in pediatric health outcomes. The progress we are seeing in pediatric health outcomes is in part due to the advancement in medicines that have been specifically studied in and approved for use in children.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MAY 8, 2023
The brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.
PharmaVoice
MAY 8, 2023
The nonprofit generics maker still sees a need for low-cost insulin despite recent moves by major drugmakers to slash the prices of their popular products.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
MAY 8, 2023
Although approvals are off to a slow start in oncology, the agency has been living in the fast lane for neurological disorders and more.
STAT
MAY 8, 2023
“S o, you don’t have it in liquid form?” I asked. The answer, as usual, was no. I hung up the phone and sighed.
Fierce Healthcare
MAY 8, 2023
UnitedHealth extends its hot streak as the most profitable payer in Q1 pminemyer Mon, 05/08/2023 - 13:28
Pharmacy Times
MAY 8, 2023
Due to the disease’s chronicity, the variability in treatment response and drug safety profiles, and the availability of multiple therapies, switching or discontinuing treatments is common in psoriasis.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
MAY 8, 2023
EQRx, a company that aimed to lower drug prices by introducing inexpensive me-too medicines, said Tuesday that it has abandoned that plan and is laying off nearly 60% of its workforce. The company’s original business plan was to create new medicines in the same categories as high-priced cancer and specialty drugs and to sell them at lower prices through a “global buyers club” that included insurers and hospitals.
Pharmacy Times
MAY 8, 2023
Comorbidities and cognitive impairment worsen non-adherence to anti-seizure medications in older adults.
STAT
MAY 8, 2023
Plummeting costs of DNA sequencing technologies are injecting urgency into the longstanding debate over whether to dive deeper into the genomes of more infants — even apparently healthy ones. Experts are divided about how helpful DNA sequencing data really are. The tests often identify mutations that raise someone’s risk of developing a condition, but don’t necessarily cause the disease.
Fierce Healthcare
MAY 8, 2023
Digital health companies making a long-term play for the $100B weight loss drug market hlandi Mon, 05/08/2023 - 06:53
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 8, 2023
Pharmacists, in particular, must be cautious and deliberate in using ChatGPT to ensure that its benefits are fully realized while minimizing risk and misinformation.
Fierce Healthcare
MAY 8, 2023
WIth judge's ruling, some employers may cut off no-cost preventive care: survey fdiamond Mon, 05/08/2023 - 12:49
STAT
MAY 8, 2023
Ever since fentanyl came to dominate the U.S. illicit drug supply, doctors and patients have found buprenorphine, a key addiction-treatment medication, increasingly difficult to use. All too often, fentanyl’s potency has meant that patients transitioning to buprenorphine , a far weaker drug, experience excruciating symptoms known as “precipitated withdrawal.
Fierce Healthcare
MAY 8, 2023
A 'reckoning' in healthcare: The climate crisis and what the industry can do about it agliadkovskaya Mon, 05/08/2023 - 18:13
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 8, 2023
For the first time, the U.S. government will pay for a large study measuring whether overdoses can be prevented by so-called safe injection sites, places where people can use heroin and other illegal drugs and be revived if they take too much. The grant provides more than $5 million over four years to New York University and Brown University to study two sites in New York City and one opening next year in Providence, R.I.
European Pharmaceutical Review
MAY 8, 2023
A marketing authorisation for PRX-102 (pegunigalsidase alfa) , the first Poly(ethylene glycol) (PEG)ylated enzyme for Fabry disease, has been granted by the European Commission (EC). The approval follows the European Medicines Agency (EMA) human medicines committee’s recommendation of the enzyme replacement therapy (ERT) in February 2023. CHMP recommends first pegylated enzyme for Fabry disease… The PEGylated enzyme replacement therapy Chiesi Global Rare Diseases and Protalix BioTherapeutics, In
STAT
MAY 8, 2023
Amid rising demand for drugs like Wegovy , Ozempic, and Mounjaro that can lead to significant weight loss , some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health. Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass.
Fierce Pharma
MAY 8, 2023
As COVID vaccine sales plummet, BioNTech looks for new growth opportunities zbecker Mon, 05/08/2023 - 11:02
STAT
MAY 8, 2023
If you have been looking for a sense of pandemic closure, the World Health Organization’s declaration Friday that it was ending the Covid global health emergency was about as close to it as you are likely to get. The reality is that although battlefield metaphors are often employed to describe humankind’s struggle with the SARS-CoV-2 virus, there will be no 11th hour of the 11th day of the 11th month-like moment signaling that an armistice has been achieved.
The Checkup by Singlecare
MAY 8, 2023
If your goal is to prevent pregnancy, oral contraceptives are a safe, effective form of birth control. The pill has other perks too—from improved acne to reduced menstrual cramps and more regular periods. And while it’s one of the easiest methods of hormonal contraception out there, there are many different brands of birth control pills to choose from.
Drug Store News
MAY 8, 2023
New launches include the Spa Renewing Wash and Spa Calming Cleansing Cloths, which look to combine daily cleanliness with elevated self-care, the company said.
Pharmaceutical Technology
MAY 8, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Immuno-oncology in Pharmaceuticals: Microbio t a rest
The FDA Law Blog
MAY 8, 2023
By Lisa M. Baumhardt, Senior Medical Device Regulation Expert & Philip Won & Gail H. Javitt — FDA recently published a long-awaited draft guidance aimed at reducing the need for prior FDA authorization of modifications to artificial intelligence/machine learning (AI/ML)-enabled device software functions (ML-DSFs). The draft guidance, “Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software
STAT
MAY 8, 2023
NEW YORK — The Bronx auditorium was bustling with pregnant people, and Detective Fred Washington of the police department’s community affairs bureau had a promise. “If anyone goes into labor, NYPD is here to help!” he shouted to the hundreds of people who had come from around the Bronx to the community baby shower to receive donated diapers, pacifiers, and children’s clothing.
Drug Store News
MAY 8, 2023
Set for May 12, the one-day pop-up event will offer Mother's Day prep activities and samples of Breyers CarbSmart.
STAT
MAY 8, 2023
For season 2 of “Color Code,” we’re zooming into the birthplace of American suburbs and the place where I grew up: Long Island, N.Y. Suburban communities in the U.S. have a reputation for being largely white, wealthy, and healthy, but the reality is much more complex. People from a wide swath of racial, ethnic, and socioeconomic backgrounds call suburbia home.
Drug Store News
MAY 8, 2023
Watkins' appointment comes less than a month after the news that Charles Redfield would step down from the position on May 1.
STAT
MAY 8, 2023
A long-running flurry of hospital and medical group acquisitions in Pennsylvania — especially among the giants UPMC and Highmark Health — forced Geisinger to make a bigger move of its own and to sell to Kaiser Permanente. That’s according to Gail Wilensky, who has been on the board of Geisinger since 2010. Wilensky is an economist by training, and also is well-known in health policy circles.
Fierce Pharma
MAY 8, 2023
Pfizer, AstraZeneca run it back in IDEA Pharma's annual innovation rankings kdunleavy Mon, 05/08/2023 - 10:21
Expert insights. Personalized for you.
469 
Let's personalize your content